Live-blogging roundtable talks on anti-cloning bills tomorrow
First, the video above is the intro to a short series of University of Minnesota tutorials on stem cell research.
I'm doing some prep for tomorrow's U of M roundtable discussion on how the anti-cloning amendments going through the state legislature would affect the business community.
I hope to live-blog it at 9 a.m., so stay tuned!
Here's the announcement from the U:
Create a More Connected Minnesota
MPR News is your trusted resource for the news you need. With your support, MPR News brings accessible, courageous journalism and authentic conversation to everyone - free of paywalls and barriers. Your gift makes a difference.
MN biomedical business leaders to discuss potential impact of anti-research bill
MINNEAPOLIS / ST. PAUL (April 26, 2011) – Biomedical business leaders will gather at a roundtable event tomorrow to discuss the impact an anti-research bill would have on the Minnesota bio-business community if it passes.
The legislation – along with language now included in the omnibus higher education appropriations bill, and the omnibus health and human services finance bill – is an attack on research disguised as a prohibition on human cloning, and is rapidly moving through the Minnesota legislature. It includes language that would make one type of human embryonic stem cell research a crime. The bill would not just ban a particular type of stem cell research. It would send a chilling message to Minnesota’s biomedical business community that special interest groups will dictate what types of research – and prospects for economic growth – are permitted. Event Information When and Where: 9- 10 a.m. tomorrow (April 27, 2011) at the U of M McGuire Translational Research Building, located immediately north of the TCF Bank Football stadium. Parking passes can be validated. Who will speak:
Aaron Friedman, M.D., the U of M Vice President for Health Sciences and Dean of the Medical School.
Robert Rizza, M.D., Executive Dean for Research from the Mayo Clinic.
Business leaders including Doug Kohrs (Tornier), Rob Cohen (Miromatrix), and Matt Kyle (Circle Biologics).
U of M stem cell faculty members including Jonathan Slack (director of the Stem Cell Institute), Dan Kaufman (cancer researcher) and Meri Firpo (diabetes researcher)
The roundtable discussion will also open up to the media.
Roundtable discussion to also include stem cell researchers, U of M and Mayo leaders